PMCPA Case
| Case number | AUTH/3560/9/21 |
| Complainant | Anonymous health professional (described themself as a nurse); non-contactable |
| Company | Sanofi |
| Issue | Alleged pressure/harassment by an account executive to sign up to a diabetes therapy review service |
| Activity/service | “Diabetes Therapy Review Service” (described by Sanofi as a medically led MEGS delivered by a third-party provider) |
| Applicable Code year | 2021 |
| Clauses considered | Clause 17.2; Clause 17.9 |
| Panel decision | No breach of Clause 17.2; No breach of Clause 17.9 (No breach overall) |
| Complaint received | 26 September 2021 |
| Case completed | 31 May 2022 |
| Appeal | No appeal |
| Sanctions | None |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.